Hypha Discovery Ltd
Is this your company? Claim this profile
Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Hypha Discovery Ltd is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:United Kingdom
Founded:2003
Employees:2,288
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
North America
Regulatory Approvals
Drug Approval ECFKRX
PMDA · #APR-HQYV462B · 2018-05-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-IQGN9IZO
Issued: 2020-12-11
Expires: 2025-10-24
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-O7RMBO19
Issued: 2020-01-24
Expires: 2025-07-13
Loading CDMO intelligence...
Key facts about Hypha Discovery Ltd
- Hypha Discovery Ltd is headquartered in the United Kingdom.
- Hypha Discovery Ltd was founded in 2003.
- Hypha Discovery Ltd has 2,288 employees.
- Hypha Discovery Ltd's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Hypha Discovery Ltd
Directory pages this company appears in, each with the full list of matching manufacturers.